Advances in host cell engineering, better expression of cell lines and optimization of cell culture processes, have greatly accelerated upstream processing in the last decade, resulting in today's antibody production yield of 10g/L or more. Meanwhile, newer platforms and advanced technologies continue to present opportunities for companies to striv
14-15 August 2023